LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced it has filed its Annual Report on Form 10-K for the year ended ...
XBI has nearly 50 points of upside to reach its previous all-time high, and 2026 biotech industry conditions may help it get ...
StockStory.org on MSN
A look back at biotechnology stocks’ Q4 earnings: Incyte (NASDAQ:INCY) vs. the rest of the pack
Looking back on biotechnology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Incyte ...
The longevity biotechnology industry is rapidly evolving with the amount of academic funding and venture investment increasing at the exponential pace. Over thirty longevity startups and approximately ...
Tivic Health Systems is developing immune‑modulating therapies for conditions, such as radiation exposure, while expanding ...
Shares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than ...
The average one-year price target for Nautilus Biotechnology (NasdaqCM:NAUT) has been revised to $4.08 / share. This is an ...
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
1.1a Congress must establish a National Biotechnology Coordination Office (NBCO) within the Executive Office of the President with a director, appointed by the President, who would coordinate ...
Do you want to be at the forefront of the rapidly growing biotechnology field? Do you want to develop products derived from living organisms and biomolecules? Do you have a passion for biochemistry, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results